SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-109360
Filing Date
2022-10-17
Accepted
2022-10-17 16:36:57
Documents
6
Effectiveness Date
2022-10-17

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2228292d1_s8.htm S-8 70066
2 EXHIBIT 5.1 tm2228292d1_ex5-1.htm EX-5.1 7770
3 EXHIBIT 23.1 tm2228292d1_ex23-1.htm EX-23.1 2366
4 EXHIBIT 23.2 tm2228292d1_ex23-2.htm EX-23.2 2033
5 EX-FILING FEES tm2228292d1_ex107.htm EX-FILING FEES 13994
6 GRAPHIC tm2228292d1_ex5-1img001.jpg GRAPHIC 3265
  Complete submission text file 0001104659-22-109360.txt   102233
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-267910 | Film No.: 221314069
SIC: 2834 Pharmaceutical Preparations